New patent expiration for Takeda Pharms drug MYDAYIS – DrugPatentWatch
Annual Drug Patent Expiration for MYDAYIS
Mydayis is a drug marketed by Takeda Pharms Usa and included in one NDA. It is available from a single supplier. There are three patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for MYDAYIS.
This drug has thirty-one patent family members in thirty countries.
The generic ingredient in MYDAYIS is aspartate amphetamine; amphetamine sulfate; dextroamphetamine dying; dextroamphetamine sulfate. One registered supplier for this compound. Additional details are available on amphetamine aspartate; amphetamine sulfate; dextroamphetamine dying; dextroamphetamine sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published on Recently expired Patent for Takeda Pharms MYDAYIS drug
